NASDAQ : ABVX
ABIVAX Société Anonyme — Financial statements
Healthcare · Biotechnology · France
Last price 86.59 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.69B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
ABIVAX Société Anonyme (ABVX) reported revenue of 4.67M EUR (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Other Revenue | 4.67M | 4.57M | 12.43M | 4.57M | 4.50M | 4.20M |
| Revenue | 4.67M | 4.57M | 12.43M | 4.57M | 4.50M | 4.20M |
| Gross Profit | 4.67M | 4.57M | 12.43M | 4.57M | 4.50M | 4.20M |
| Selling, General & Admin | 90.04M | 72.86M | 38.90M | 28.82M | 7.49M | 5.58M |
| Research & Development | 207.69M | 177.76M | 146.53M | 103.18M | 48.30M | 47.78M |
| Other Operating Expenses | -360.00K | -23.00K | -47.00K | -78.00K | -36.00K | |
| Operating Expenses | 297.37M | 250.62M | 185.41M | 131.95M | 55.71M | 53.33M |
| Operating Income | -292.70M | -246.06M | -172.98M | -127.38M | -51.20M | -49.12M |
| Interest Expense | -23.70M | -28.48M | -12.43M | -13.83M | -6.94M | -3.56M |
| Interest & Investment Income | 5.60M | 5.60M | 8.25M | 2.42M | ||
| Currency Exchange Gain (Loss) | -1.66M | -1.56M | 2.72M | -5.57M | ||
| Other Non Operating Income (Expenses) | -50.28M | -64.49M | -1.80M | -6.58M | 9.59M | 2.51M |
| EBT Excluding Unusual Items | -362.74M | -334.98M | -176.24M | -150.94M | -48.55M | -50.17M |
| Impairment of Goodwill | -13.63M | |||||
| Other Unusual Items | -38.48M | 4.73M | 3.20M | 1.45M | 7.72M | |
| Pretax Income | -401.22M | -330.25M | -176.24M | -147.74M | -60.74M | -42.45M |
| Income Tax Expense | 5.85M | |||||
| Net Income | -401.22M | -336.10M | -176.24M | -147.74M | -60.74M | -42.45M |
| Net Income to Common | -401.22M | -336.10M | -176.24M | -147.74M | -60.74M | -42.45M |
| Shares Outstanding (Basic) | 77.46M | 69.53M | 63.05M | 43.07M | 19.09M | 15.46M |
| Shares Outstanding (Diluted) | 77.46M | 69.53M | 63.05M | 43.07M | 19.09M | 15.46M |
| EPS (Basic) | -5.18 | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 |
| EPS (Diluted) | -5.18 | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 |
| Free Cash Flow | -197.26M | -161.27M | -154.71M | -97.39M | -54.22M | -45.09M |
| Free Cash Flow Per Share | -2.55 | -2.32 | -2.45 | -2.26 | -2.84 | -2.92 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -6,270.37% | -5,384.14% | -1,392.11% | -2,784.78% | -1,136.60% | -1,168.74% |
| Profit Margin | -8,595.07% | -7,354.53% | -1,418.33% | -3,230.00% | -1,348.28% | -1,010.04% |
| Free Cash Flow Margin | -4,225.90% | -3,528.91% | -1,245.07% | -2,129.32% | -1,203.64% | -1,072.92% |
| EBITDA | -291.55M | -244.98M | -171.88M | -126.67M | -50.72M | -49.07M |
| D&A For EBITDA | 1.15M | 1.07M | 1.10M | 707.00K | 485.00K | 54.00K |
| EBIT | -292.70M | -246.06M | -172.98M | -127.38M | -51.20M | -49.12M |
| Revenue as Reported | 5.03M | 4.57M | 12.45M | 4.62M | 4.58M | 11.96M |
Balance sheet
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 387.99M | 516.68M | 144.22M | 251.94M | 26.95M | 60.70M |
| Short-Term Investments | 14.39M | 13.70M | 136.00K | 9.19M | ||
| Cash & Short-Term Investments | 402.38M | 530.38M | 144.36M | 261.13M | 26.95M | 60.70M |
| Other Receivables | 12.85M | 10.49M | 15.66M | 19.10M | 8.32M | 8.34M |
| Receivables | 12.85M | 10.49M | 15.66M | 19.10M | 8.32M | 8.34M |
| Prepaid Expenses | 4.39M | 2.65M | 3.23M | 5.75M | 915.00K | 721.00K |
| Other Current Assets | 8.00M | 7.72M | 7.42M | -1.00K | 5.72M | |
| Total Current Assets | 427.62M | 551.24M | 170.67M | 285.97M | 36.18M | 75.48M |
| Property, Plant & Equipment | 1.52M | 2.09M | 2.67M | 878.00K | 1.59M | 305.00K |
| Goodwill | 18.42M | 18.42M | 18.42M | 18.42M | 18.42M | 32.01M |
| Other Intangible Assets | 6.61M | 6.61M | 6.61M | 6.60M | 6.61M | 93.00K |
| Other Long-Term Assets | 8.04M | 5.98M | 6.87M | 15.19M | 12.74M | 1.34M |
| Total Assets | 462.21M | 584.34M | 205.23M | 327.06M | 75.54M | 109.23M |
| Accounts Payable | 39.01M | 37.55M | 43.80M | 47.22M | 15.47M | 18.56M |
| Accrued Expenses | 7.51M | 7.12M | 4.53M | 5.95M | 2.19M | 1.96M |
| Current Portion of Long-Term Debt | 42.84M | 34.39M | 33.01M | 11.18M | ||
| Current Portion of Leases | 1.07M | 1.30M | 932.00K | 379.00K | 545.00K | 170.00K |
| Current Income Taxes Payable | 177.00K | 17.00K | 184.00K | 127.00K | 112.00K | 243.00K |
| Current Unearned Revenue | 52.00K | 133.00K | 162.00K | |||
| Other Current Liabilities | 23.91M | 17.03M | 1.72M | 2.58M | 10.00K | |
| Total Current Liabilities | 71.69M | 63.02M | 94.00M | 90.69M | 51.46M | 32.27M |
| Long-Term Debt | 30.24M | 64.02M | 39.54M | 14.84M | 40.27M | |
| Long-Term Leases | 137.00K | 554.00K | 1.43M | 160.00K | 839.00K | 43.00K |
| Pension & Post-Retirement Benefits | 696.00K | 627.00K | 756.00K | 629.00K | 610.00K | 693.00K |
| Long-Term Deferred Tax Liabilities | 5.85M | |||||
| Other Long-Term Liabilities | 23.42M | 28.85M | 4.44M | 31.00K | 605.00K | 10.03M |
| Total Liabilities | 95.94M | 129.14M | 164.64M | 131.05M | 68.36M | 83.30M |
| Common Stock | 798.00K | 785.00K | 633.00K | 629.00K | 223.00K | 168.00K |
| Additional Paid-In Capital | 1.23B | 1.19B | 478.90M | 478.22M | 150.48M | 107.58M |
| Retained Earnings | -864.96M | -738.48M | -438.88M | -282.95M | -143.51M | -81.81M |
| Comprehensive Income & Other | 1.77M | 2.31M | -75.00K | 112.00K | 1.00K | |
| Shareholders' Equity | 366.27M | 455.20M | 40.58M | 196.01M | 7.19M | 25.93M |
| Total Liabilities & Equity | 462.21M | 584.34M | 205.23M | 327.06M | 75.54M | 109.23M |
| Total Debt | 1.21M | 32.09M | 109.22M | 74.47M | 49.23M | 51.65M |
| Net Cash (Debt) | 401.17M | 498.29M | 35.14M | 186.66M | -22.28M | 9.05M |
| Net Cash Per Share | 5.18 | 7.17 | 0.56 | 4.33 | -1.17 | 0.59 |
| Filing Date Shares Outstanding | 79.82M | 79.19M | 63.38M | 62.92M | 42.54M | 16.75M |
| Total Common Shares Outstanding | 79.82M | 78.54M | 63.35M | 62.92M | 22.30M | 16.76M |
| Working Capital | 355.94M | 488.22M | 76.67M | 195.28M | -15.28M | 43.22M |
| Book Value Per Share | 4.59 | 5.80 | 0.64 | 3.12 | 0.32 | 1.55 |
| Tangible Book Value | 341.24M | 430.18M | 15.56M | 170.99M | -17.84M | -6.16M |
| Tangible Book Value Per Share | 4.28 | 5.48 | 0.25 | 2.72 | -0.80 | -0.37 |
| Buildings | 3.22M | 3.20M | 2.82M | 1.35M | 1.62M | 828.00K |
| Machinery | 1.24M | 1.07M | 1.21M | 1.02M | 782.00K | 402.00K |
Cash flow statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -401.22M | -336.10M | -176.24M | -147.74M | -60.74M | -42.45M |
| Depreciation & Amortization | 1.29M | 1.07M | 1.10M | 707.00K | 485.00K | 298.00K |
| Other Amortization | 4.00K | |||||
| Asset Writedown & Restructuring Costs | 13.63M | |||||
| Loss (Gain) From Sale of Investments | -16.00K | -34.00K | -108.00K | |||
| Stock-Based Compensation | 63.79M | 35.40M | 20.22M | 8.18M | -1.16M | 828.00K |
| Other Operating Activities | 154.67M | 134.85M | -561.00K | 20.49M | -4.04M | -3.06M |
| Change in Accounts Receivable | -271.00K | 7.04M | 4.59M | -14.23M | 312.00K | -1.98M |
| Change in Accounts Payable | -18.50M | -6.21M | -3.44M | 31.76M | -2.39M | 1.14M |
| Change in Unearned Revenue | -106.00K | 710.00K | 1.76M | -81.00K | -26.00K | -41.00K |
| Change in Income Taxes | 3.34M | 2.11M | -1.49M | 3.82M | 100.00K | 209.00K |
| Operating Cash Flow | -197.02M | -161.13M | -154.07M | -97.13M | -53.94M | -45.05M |
| Capital Expenditures | -245.00K | -142.00K | -640.00K | -265.00K | -288.00K | -47.00K |
| Cash Acquisitions | -2.91M | -2.18M | ||||
| Sale (Purchase) of Intangibles | -3.00K | -35.00K | ||||
| Other Investing Activities | -7.75M | -8.05M | 16.41M | -7.83M | -8.79M | -4.01M |
| Investing Cash Flow | -8.00M | -8.19M | 15.76M | -8.10M | -12.03M | -6.23M |
| Long-Term Debt Issued | 47.94M | 55.84M | 24.91M | |||
| Long-Term Debt Repaid | -59.53M | -13.17M | -40.71M | -9.80M | -5.86M | |
| Lease Payments | -1.10M | -911.00K | -458.00K | -529.00K | -301.00K | -249.00K |
| Net Debt Issued (Repaid) | -85.38M | -59.53M | 34.78M | 15.13M | -9.80M | 19.06M |
| Issuance of Common Stock | 654.10M | 653.94M | 434.00K | 353.39M | 46.37M | 69.68M |
| Other Financing Activities | -44.09M | -47.10M | -7.00M | -33.23M | -4.36M | -6.06M |
| Financing Cash Flow | 524.63M | 547.31M | 28.21M | 335.29M | 32.21M | 82.68M |
| Foreign Exchange Rate Adjustments | -2.26M | -10.25M | 2.38M | -5.07M | ||
| Miscellaneous Cash Flow Adjustments | 9.69M | 4.73M | -1.00K | |||
| Net Cash Flow | 327.05M | 372.46M | -107.72M | 224.99M | -33.75M | 31.40M |
| Free Cash Flow | -197.26M | -161.27M | -154.71M | -97.39M | -54.22M | -45.09M |
| Free Cash Flow Margin | -4,225.90% | -3,528.91% | -1,245.07% | -2,129.32% | -1,203.64% | -1,072.92% |
| Free Cash Flow Per Share | -2.55 | -2.32 | -2.45 | -2.26 | -2.84 | -2.92 |
| Levered Free Cash Flow | -125.90M | -118.32M | -102.37M | -57.23M | -34.80M | -36.75M |
| Unlevered Free Cash Flow | -111.09M | -100.52M | -94.60M | -48.59M | -30.46M | -34.52M |
| Free Cash Flow After Leases | -198.37M | -162.18M | -155.17M | -97.92M | -54.52M | -45.34M |
| Cash Interest Paid | 2.65M | 6.49M | 7.70M | 5.28M | 4.01M | 1.91M |
| Change in Working Capital | -15.54M | 3.65M | 1.42M | 21.27M | -2.00M | -668.00K |
Ratios
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.69B | 11.00B | 443.27M | 679.99M | 110.78M | 531.29M |
| Enterprise Value | 7.25B | 10.40B | 330.47M | 611.13M | 134.59M | 562.51M |
| Last Close Price | 86.59 | 134.85 | 7.32 | 10.70 | ||
| PS Ratio | 1,442.83 | 2,050.49 | 34.46 | 134.50 | 23.01 | 111.15 |
| PB Ratio | 18.39 | 20.59 | 10.55 | 3.14 | 14.42 | 18.01 |
| P/TBV Ratio | 19.74 | 21.78 | 27.52 | 3.60 | ||
| EV/Sales Ratio | 1,358.84 | 1,937.64 | 25.69 | 120.88 | 27.95 | 117.68 |
| Debt / Equity Ratio | 0.00 | 0.07 | 2.69 | 0.38 | 6.85 | 1.99 |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -0.87 | -0.95 | 3.10 | -0.35 |
| Net Debt / EBITDA Ratio | 1.38 | 2.03 | 0.20 | 1.47 | -0.44 | 0.18 |
| Net Debt / FCF Ratio | 2.03 | 3.09 | 0.23 | 1.92 | -0.41 | 0.20 |
| Asset Turnover | 0.02 | 0.01 | 0.05 | 0.02 | 0.05 | 0.05 |
| Quick Ratio | 5.79 | 8.58 | 1.70 | 3.09 | 0.69 | 2.14 |
| Current Ratio | 5.96 | 8.75 | 1.82 | 3.15 | 0.70 | 2.34 |
| Return on Equity (ROE) | -252.35% | -135.58% | -148.98% | -145.41% | -366.75% | -193.69% |
| Return on Assets (ROA) | -62.88% | -38.95% | -40.62% | -39.55% | -34.64% | -34.01% |
| Return on Capital Employed (ROCE) | -75.00% | -47.20% | -155.50% | -53.90% | -212.60% | -63.80% |
| Earnings Yield | -6.70% | -3.59% | -41.16% | -24.02% | -58.59% | -9.09% |
| FCF Yield | -2.87% | -1.72% | -36.13% | -15.83% | -52.31% | -9.65% |
| Buyback Yield / Dilution | -22.38% | -10.28% | -46.39% | -125.57% | -23.53% | -7.84% |